Atropine (2020) capacitación - video

So atropine is an anticholinergic or anti-parasympathetic sometimes referred to as a parasympatholytic

drug.

A parasympatholytic agent is a substance or activity that reduces the activity of the

parasympathetic nervous system.

Now the parasympathetic nervous system is often conversationally described as the "Rest

and Digest" portion of the autonomic nervous system.

Atropine blocks that action.

Atropine is one of a few ACLS medications that can be delivered via endotracheal tube,

vascular access, however, in most cases would be the preference.

Atropine is the drug of choice for symptomatic sinus bradycardia and may be beneficial in

the presence of atrioventricular nodal blocks.

It’s well known that atropine use during Pulseless Electrical Activity otherwise known

as PEA and Asystole usually doesn’t really have a therapeutic benefit.

Let’s not forget that Atropine will most likely not affect type 2 second-degree or

third degree AV blocks or a block in non-nodal tissue as well.

So for bradycardia, with or without Acute Coronary Syndrome give atropine 1 mg every

3-5 minutes as needed, not to exceed a total dose of .04 mg per kg to a total of 3mg.

It’s recommended to use a shorter dosing interval such as every 3 minutes and higher

doses in severe clinical conditions.

But for organophosphate poisoning 2 to 4 mg or higher to actually reverse those life-threatening

symptoms of such a poisoning.

The good news is intraosseous administration has been found to be just as effective as

intravenous infusion for rapid delivery of atropine.

Now because large amounts of atropine may be required for patients with organophosphate

poisoning, reconstitution of powdered atropine may be a viable option, especially when we’re

talking about mass-casualty settings.

Remember to utilize personal protective equipment while treating patients of organophosphate

toxicity to reduce or prevent the risk of cross-contamination of rescuers.

Atropine (2020)